Sunshine Biopharma Inc. (SBFM): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-100, first reflected in a filing dated 2024-05-20; 1-for-10, first reflected in a filing dated 2026-08-13. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

4.91M
As of 2025-12-31
2.39M
As of 2026-06-30
769.40M2010-12-31: 30.69M2011-12-31: 48.73M2012-12-31: 51.42M2013-12-31: 60.30M2014-12-31: 73.55M2015-12-31: 198.27M2016-12-31: 769.40M2017-12-31: 45.94M2018-12-31: 4.28M2019-12-31: 35.32M2020-12-31: 1.73M2021-12-31: 2.59M2022-12-31: 22.59M2023-12-31: 14.0K2024-12-31: 2.58M2025-12-31: 4.91M4.91M
2010-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-12-314.91M+90.1%2026-04-03, Balance as of period end
2024-12-312.58Mn/m2026-04-03, Balance as of period end
2023-12-3114.0Kn/c2025-04-01, Balance as of period end
2022-12-3122.59M+771.6%2024-03-28, Balance as of period end
2021-12-312.59Mn/c2023-04-04, Balance as of period end
2020-12-311.73M-95.1%2022-03-21, Balance as of period end
2019-12-3135.32M+724.7%2021-03-30, Balance as of period end
2018-12-314.28M-90.7%2020-05-01, Balance as of period end
2017-12-3145.94M-94.0%2019-04-12, Balance as of period end
2016-12-31769.40Mn/c2018-04-02, Balance as of period end
2015-12-31198.27M+169.6%2017-04-17, Balance as of period end
2014-12-3173.55M+22.0%2016-03-25, Balance as of period end
2013-12-3160.30M+17.3%2015-03-11, Balance as of period end
2012-12-3151.42M+5.5%2014-03-19, Balance as of period end
2011-12-3148.73M+58.8%2013-03-15, Balance as of period end
2010-12-3130.69Mn/a2012-03-19, Balance as of period end